Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.

Rodney Taylor is an Otolaryngologist in Baltimore, Maryland. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Teratocarcinosarcoma, Olfactory Neuroblastoma, Sinus Cancer, Laryngectomy, and Tissue Biopsy.

Kevin Cullen is an Oncologist in Baltimore, Maryland. Dr. Cullen is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Olfactory Neuroblastoma, Teratocarcinosarcoma, and Laryngeal Cancer. Dr. Cullen is currently accepting new patients.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy.

Dr. Masaru Ishii graduated from University of Pennsylvania Perelman School of Medicine. His clinical specialties include surgical management of nasal airway obstruction, chronic sinusitis and sinonasal tumors, as well as endoscopic surgery for skull base tumors. Dr. Ishii is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Cerebrospinal Fluid Leak, Prolactinoma, Olfactory Neuroblastoma, Septoplasty, and Endoscopic Transnasal Transsphenoidal Surgery.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.

Nicholas Rowan is a sinus and skull base surgeon who helps patients with conditions such as deviated septum, nasal congestion, nasal obstruction, sinus pressure and chronic sinusitis, as well as complex issues like loss of smell, sinus cancers, cerebrospinal fluid (CSF) leaks and tumors that grow near the brain. He frequently performs nasal polyp surgery and endoscopic sinus procedures, using minimally invasive approaches to help patients recover quickly and breathe more easily. For tumors of the skull base or brain, he works closely with neurosurgeons and cancer specialists to deliver coordinated, comprehensive care. Dr. Rowan’s research is focused on improving patients’ quality of life and long-term outcomes after sinus and skull base surgery. A major part of his work involves studying the sense of smell — not just how to restore it, but how it reflects overall health. He explores how smell loss may be an early warning sign of unhealthy aging, frailty or cognitive decline. Through this work, he aims to better understand the biological link between the nose and brain, and what it can reveal about a person’s health trajectory. He works closely with biomedical engineers to develop novel diagnostic and therapeutic technologies, and he is the principal investigator of multiple ongoing clinical trials that are testing new treatments for chronic sinusitis and nasal polyps. A frequent speaker at national and international conferences, Dr. Rowan shares insights from his innovative research and surgical experience. He leads courses and delivers lectures on advanced sinus and skull base techniques, smell loss and the evolving science behind how nasal health connects to overall well-being. Dr. Rowan is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Sinusitis, Anosmia, Pituitary Tumor, Endoscopy, and Septoplasty.

Dr. Kofi Derek Owusu Boahene is a professor of otolaryngology-head and neck surgery and dermatology at the Johns Hopkins University School of Medicine. He is the Director of the Division of Facial Plastics and Reconstructive Surgery and the director for the facial plastics fellowship training program. His practice encompasses the entire spectrum of facial plastic and reconstructive surgery including cosmetic and reconstructive aspects. Dr. Boahene is a leading expert in facial paralysis surgery and facial nerve injuries and has pioneered innovative treatment protocols and surgical techniques in facial reanimation. He is the director of the Johns Hopkins Facial Nerve center dedicated to restoring facial balance, symmetry and animation to those who have suffered from facial paralysis and facial nerve disorders. As an expert microsurgeon, Dr. Boahene routinely performs some of the most complex facial reconstruction procedures on the face including rebuilding of an entire nose, lip, jaw and facial defects resulting from cancer treatment, traumatic injuries or as a result of birth defects. He uses cutting edge 3-D technology, image-guided technology and tissue transplanted from other parts of the body to restore or replace missing tissues. He is a key member of the Johns Hopkins facial transplant program. His cosmetic experience is broad and draws from patients across the globe. He routinely performs rhinoplasties, eyelid surgery, face lifts and other facial enhancing procedures. As a skull base surgeon, Dr. Boahene has pioneered minimally invasive techniques for removal of skull base and brain tumors, repairing CSF leaks and has authored a major textbook on this subject. Dr. Boahene received his undergraduate degree from the University of Central Arkansas. He graduated summa cum laude from Meharry Medical College in Nashville, Tennessee, completed a five-year surgical residency training program in otolaryngology-head and neck surgery at the Mayo Clinic in Rochester, Minnesota, and received fellowship training in facial plastic and reconstructive surgery at the University of Minnesota. As the recipient of the prestigious Mayo Brothers Distinguished Fellowship Award, Dr. Boahene was awarded additional craniofacial surgery training in Adelaide, Australia. He also received the Jack R. Anderson Prize for Scholastic Excellence for attaining the highest score nationally on the American Academy of Facial Plastic and Reconstructive Surgery certification exam. Dr. Boahene serves as on the Board of Governors or the American Academy Facial Plastic and Reconstructive Surgery. He is a member of several professional organizations, including the American Academy of Facial Plastic and Reconstructive Surgery and the American Academy of Otolaryngology-Head and Neck Surgery. In 1993, Dr. Kofi Boahene received the Alpha Omega Alpha Medical. Dr. Boahene is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, Septoplasty, and Gastrostomy.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

William Regine is a Radiation Oncologist in Baltimore, Maryland. Dr. Regine is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Pancreatic Cancer, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Anal Cancer.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer.

Murugappan “Murray” Ramanathan is an experienced sinus and skull base surgeon with a high-volume clinical presence at Johns Hopkins Health Care and Surgery Center in Bethesda and Suburban Hospital. He specializes in complex revision endoscopic sinus surgery, endoscopic approaches to the orbit, and the endoscopic management of sinonasal and skull base tumors, including inverted papilloma, esthesioneuroblastoma (also known as olfactory neuroblastoma) and pituitary tumors. He routinely collaborates with colleagues in neurosurgery, ophthalmology, head and neck oncology, and facial plastic surgery to deliver multidisciplinary, patient-centered care. Dr. Ramanathan has consistently been recognized for his patient-centered approach to care as a “Top Doctor” by Bethesda Magazine, Washingtonian, Northern Virginia Magazine and Castle Connolly. He earned his undergraduate degree from Yale University and medical degree from the University of Texas Medical Branch at Galveston. Dr. Ramanathan completed an internship in general surgery and residency in otolaryngology–head and neck surgery at Johns Hopkins, followed by fellowship training in advanced endoscopic sinus and minimally invasive skull base surgery at Johns Hopkins. He joined the Johns Hopkins faculty in 2010. Dr. Ramanathan is the vice director of clinical operations for the Johns Hopkins Department of Otolaryngology–Head and Neck Surgery, overseeing the delivery and integration of otolaryngologic care at nine ambulatory clinic sites and five hospitals within Johns Hopkins Medicine. He is passionate about continuously evaluating and improving care delivery processes across all clinical sites for the department. As a surgeon-scientist, Dr. Ramanathan leads a National Institutes of Health-funded research program that was among the first to establish the link between air pollution and chronic rhinosinusitis from an epidemiologic and basic science perspective. He has received numerous prestigious research awards and grants; has published over 110 peer-reviewed articles, reviews and book chapters; and is frequently invited to speak about his research at national and international meetings. Dr. Ramanathan holds multiple national leadership roles, including chair of the CORE Grants General Section for the American Academy of Otolaryngology–Head and Neck Surgery. Dr. Ramanathan is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Pituitary Tumor, Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and Ethmoiditis.

Vassiliki Saloura is an Otolaryngologist and an Oncologist in Baltimore, Maryland. Dr. Saloura is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Wolf-Hirschhorn Syndrome, Glioma, and Tongue Cancer.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Lee Akst, M.D., specializes in treating the larynx (voicebox), in particular the treatment of voice and swallowing disorders. He is a leading laryngologist in office-based procedures such as vocal fold injection augmentation, pulsed KTP laser treatment, and laryngeal botox injection. In the operating room, Dr. Akst specializes in phonosurgery for the treatment of vocal cord disease, with emphasis on voice restoration and improvement. A strong focus of his practice involves the use of pulsed angiolytic lasers, which allow for subspecialized care of laryngeal papillomas, laryngeal dysplasia, and early vocal cord cancers while preserving the quality and strength of the voice. Dr. Akst is a national leader in the field of laryngology and serves in leadership roles for the American Laryngological Association, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology-Head and Neck Surgery. He lectures extensively on the treatment of laryngeal disease, teaching other physicians how to care for patients with voice and swallowing concerns. His research interests include the development of robotic laryngeal surgery, the study of voice and swallowing complaints in the elderly, and the advancement of pulsed lasers for the treatment of laryngeal diseases with a focus on leukoplakia. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Akst is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Spasmodic Dysphonia, Laryngitis, Perichondritis, Endoscopy, and Laryngectomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Laryngectomy, and Gastrostomy.